Evidence map›Paper›PMID 38957690›Full record

ArticleOpen forum infectious diseases2024

Diagnostic Yield of Urine Xpert MTB/RIF Ultra in Adults With Suspected Extrapulmonary Tuberculosis.

Robert Ndege, Martin Rohacek, Farida Bani, Omary Ngome, James Okuma, Mohamed Sasamalo, Dorcas Mnzava, Klaus Reither, Fiona Vanobberghen, Jerry Hella and 2 more

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Closing gaps through innovation in the tuberculosis pathology value chain.Journal of clinical tuberculosis and other mycobacterial diseases · 2026
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Robert NdegeBiomedical Research and Clinical Trials Department, Ifakara Health Institute, Ifakara, Tanzania.ORCID https://orcid.org/0000-0002-1253-8970
Martin RohacekBiomedical Research and Clinical Trials Department, Ifakara Health Institute, Ifakara, Tanzania.
Farida BaniBiomedical Research and Clinical Trials Department, Ifakara Health Institute, Ifakara, Tanzania.
Omary NgomeBiomedical Research and Clinical Trials Department, Ifakara Health Institute, Ifakara, Tanzania.
James OkumaDepartment of Medicine, Swiss Tropical and Public Health Institute, Allschwil, Switzerland.
Mohamed SasamaloBiomedical Research and Clinical Trials Department, Ifakara Health Institute, Ifakara, Tanzania.
Dorcas MnzavaBiomedical Research and Clinical Trials Department, Ifakara Health Institute, Ifakara, Tanzania.
Klaus ReitherDepartment of Medicine, Swiss Tropical and Public Health Institute, Allschwil, Switzerland.
Fiona VanobberghenDepartment of Medicine, Swiss Tropical and Public Health Institute, Allschwil, Switzerland.
Jerry HellaBiomedical Research and Clinical Trials Department, Ifakara Health Institute, Ifakara, Tanzania.
Daniel H ParisDepartment of Medicine, Swiss Tropical and Public Health Institute, Allschwil, Switzerland.
Maja WeisserBiomedical Research and Clinical Trials Department, Ifakara Health Institute, Ifakara, Tanzania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We assessed the diagnostic yield of urine GeneXpert MTB/RIF Ultra and factors associated with a positive test among adult patients suspected to have extrapulmonary tuberculosis. Urine Ultra was positive in 14% of participants with definite or probable tuberculosis. Hospitalization, disseminated tuberculosis, and human immunodeficiency virus infection were associated with a positive result.

Indexed as

diagnostic yieldextrapulmonary tuberculosishuman immunodeficiency virustuberculosisurine Xpert MTB/RIF Ultra

Identifiers

PMID38957690
PMCPMC11218765

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.